The WACC of Syros Pharmaceuticals Inc (SYRS) is 21.7%.
| Range | Selected | |
| Cost of equity | 29.30% - 58.50% | 43.90% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 48.80% | 27.90% |
| WACC | 6.5% - 36.9% | 21.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 5.54 | 9.58 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 29.30% | 58.50% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 16.63 | 16.63 |
| Cost of debt | 7.00% | 48.80% |
| After-tax WACC | 6.5% | 36.9% |
| Selected WACC | 21.7% | |